We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.80 | 1.49% | 190.40 | 189.20 | 190.40 | 192.00 | 187.40 | 189.20 | 284,402 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.85 | 410.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/12/2015 19:52 | just got notification of a corporate action. | whitebicycle | |
15/12/2015 13:55 | Yes I agree i/c lets hope the market does. | dealit | |
02/12/2015 01:17 | BlackRock, Inc. increased their holding by just short of 2m they must be confident the share price will hold at these levels. | dealit | |
24/11/2015 11:22 | Good call Norbus, I thought it might breakout but I was wrong. My top up price looks steep now but shouldn't be an issue over the the coming months. | hydrus | |
19/11/2015 08:23 | Hmm - a "66" trade. That must mean something..... | small crow | |
09/11/2015 09:59 | This may now retrace to 160; they always shoot up when there is a buyer, but soon settle back; I think they will continue slow but sure progress | norbus | |
04/11/2015 07:37 | Global sutures & staples worth around $5 billion according to chart issued in free section of this report - hxxp://www.transpare "... the market for surgical sutures and staples market is dominated by mainly Ethicon, Inc., B. Braun Melsungen AG and Covidien plc." (Ethicon is a division of J&J BTW). So would J&J be an obvious candidate for bid?? | small crow | |
04/11/2015 07:26 | Yes the US suture market range is worth 1b dollars. IMHO AMS are starting to look like a real target indeed. | dealit | |
04/11/2015 07:22 | And it gets even better - 04/11/2015 07:00 UK Regulatory (RNS & others) Advanced Medical Solutions Grp PLC US approvals for RESORBA suture range | small crow | |
03/11/2015 17:39 | positive news regarding FDA approval is almost invariably well received. | dietcoke197 | |
03/11/2015 14:20 | The Market really likes this news. | dealit | |
03/11/2015 11:58 | Great news today...Only a matter of time before this company is bid for. | ross k | |
03/11/2015 08:42 | For some reason I never get RNS alerts from lse about AMS. I get email alerts for my other companies no problem.Good news this morning, as someone commented before the USA opportunity is exciting. Wouldn't surprise me to see AMS taken out in the next couple years if keeps progressing | hydrus | |
03/11/2015 08:38 | ADVFN seem to have missed this am's RNS? | small crow | |
02/11/2015 18:40 | Just had a corporate action note from Selftrade, the dividend has been paid. | whitebicycle | |
02/11/2015 08:12 | Octopus is more VCT's. They have gradually increased their stake over the years. | bjfanc | |
30/10/2015 17:12 | Hi Norbus, what triggered your post I cannot see an announcement. | dealit | |
30/10/2015 10:12 | Octopus is a hedge fund: I remember Jin Slater looking in with a stake, ending in a mess; Hope Octopus do not create waves | norbus | |
09/9/2015 13:14 | Nice read "investors" Investec have a buy note and a target price of 170p set today. It is the growth in the USA that is very promising IMHO. | dealit | |
09/9/2015 08:13 | I feel overall steady as we go, revenue up and very encouraging growth in the USA plus an increase in the dividend payment. | dealit | |
09/9/2015 08:03 | Was expecting a bit more | zipstuck |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions